1. Home
  2. ACTU vs PLBY Comparison

ACTU vs PLBY Comparison

Compare ACTU & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • PLBY
  • Stock Information
  • Founded
  • ACTU 2015
  • PLBY 1953
  • Country
  • ACTU United States
  • PLBY United States
  • Employees
  • ACTU N/A
  • PLBY N/A
  • Industry
  • ACTU
  • PLBY Recreational Games/Products/Toys
  • Sector
  • ACTU
  • PLBY Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • PLBY Nasdaq
  • Market Cap
  • ACTU 135.0M
  • PLBY 147.5M
  • IPO Year
  • ACTU 2024
  • PLBY N/A
  • Fundamental
  • Price
  • ACTU $7.47
  • PLBY $1.47
  • Analyst Decision
  • ACTU Strong Buy
  • PLBY Hold
  • Analyst Count
  • ACTU 1
  • PLBY 1
  • Target Price
  • ACTU $20.00
  • PLBY $0.70
  • AVG Volume (30 Days)
  • ACTU 85.1K
  • PLBY 397.1K
  • Earning Date
  • ACTU 05-15-2025
  • PLBY 08-07-2025
  • Dividend Yield
  • ACTU N/A
  • PLBY N/A
  • EPS Growth
  • ACTU N/A
  • PLBY N/A
  • EPS
  • ACTU N/A
  • PLBY N/A
  • Revenue
  • ACTU N/A
  • PLBY $116,691,000.00
  • Revenue This Year
  • ACTU N/A
  • PLBY $3.96
  • Revenue Next Year
  • ACTU N/A
  • PLBY $1.75
  • P/E Ratio
  • ACTU N/A
  • PLBY N/A
  • Revenue Growth
  • ACTU N/A
  • PLBY N/A
  • 52 Week Low
  • ACTU $5.51
  • PLBY $0.52
  • 52 Week High
  • ACTU $11.99
  • PLBY $2.44
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • PLBY 52.00
  • Support Level
  • ACTU N/A
  • PLBY $1.40
  • Resistance Level
  • ACTU N/A
  • PLBY $1.55
  • Average True Range (ATR)
  • ACTU 0.00
  • PLBY 0.07
  • MACD
  • ACTU 0.00
  • PLBY -0.03
  • Stochastic Oscillator
  • ACTU 0.00
  • PLBY 22.88

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: